
SweeGen receives GRAS no objection letter from FDA for its Bestevia Reb E
SweeGen, Inc.'s proprietary Rebaudioside E is now Generally Recognized as Safe (GRAS) after FDA issues no objection letter.
SweeGen, Inc. (Rancho Santa Margarita, CA), a stevia-based sweetener company, announced that FDA issued a GRAS (Generally Recognized As Safe) No Objection Letter for Bestevia Rebaudioside E (Reb E) stevia leaf sweetener for use in foods. Used in SweeGen’s Bestevia e+ ingredient, Bestevia Reb E is produced from the stevia leaf through a non-GMO bioconversion process, and it can be used in a variety of applications, including beverage, dairy, sports nutrition, condiments, and bakery.
"Reb E is one of the main components in our Bestevia e+. It was specifically created for alcoholic and non-alcoholic beverages in response to concerns from some regarding application IP for Reb M in beverages," said Shari Joslin, vice president of application technology for SweeGen, in a press release. "BESTEVIA e+ provides a mouthfeel and taste closest to sugar."
"Bestevia e+ provides a clean, sugar-like taste at a price equivalent to sugar. In addition to the success we have with our non-GMO Bestevia Reb M and Reb D, we are excited to add Bestevia e+ to our sweetener portfolio," added Katharina Pueller, director natural sweetener business.
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





